Mississauga, ON -- (SBWIRE) -- 09/19/2016 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "AXIM Biotechnologies Signs Distribution Agreement with Rafa Pharmaceuticals."
Companies mentioned in this article include iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) and AXIM Biotechnologies Inc. (OTCQB:AXIM).
The biotechnology sector has seen a sharp rebound after the sell-off last month. The sell-off was sparked late last month after Democratic Presidential candidate Hillary Clinton commented about the pricing of the EpiPen, which was hiked significantly prompting consumer and political backlash.
The biotech sector has been under lawmakers' scrutiny over the last couple of years due to their pricing policy. Even last year, a tweet from Clinton on price gouging had sparked a sell-off in the sector. However, some deal-related news and some important drug approvals have boosted the biotech sector in the last week. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has in fact regained the levels it was trading at before last month's sell-off. However, IBB has been facing stiff resistance at around $300. It will be interesting to see if the fund can break through this level this time.
AXIM Biotechnologies Inc. (OTCQB:AXIM) is a New York City-based company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.
For more information on this press release visit: http://www.sbwire.com/press-releases/all-penny-stockscom-news-axim-biotechnologies-signs-distribution-agreement-with-rafa-pharmaceuticals-724438.htmMedia Relations Contact